Related references
Note: Only part of the references are listed.KRAS Mutation Comparison of Testing Methods and Tissue Sampling Techniques in Colon Cancer
Wilbur A. Franklin et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2010)
KRAS Genotyping of Paraffin-Embedded Colorectal Cancer Tissue in Routine Diagnostics - Comparison of Methods and Impact of Histology
Wilko Weichert et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2010)
A Commercial Real-Time PCR Kit Provides Greater Sensitivity than Direct Sequencing to Detect KRAS Mutations A Morphology-Based Approach in Colorectal Carcinoma
Barbara Angulo et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2010)
Gastrosplenic Fistula From Hodgkin's Lymphoma
Carolyn D. Seib et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
American Society of Clinical Oncology Provisional Clinical Opinion: Testing for KRAS Gene Mutations in Patients With Metastatic Colorectal Carcinoma to Predict Response to Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Therapy
Carmen J. Allegra et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
KRAS Mutations and Sensitivity to Epidermal Growth Factor Receptor Inhibitors in Colorectal Cancer: Practical Application of Patient Selection
Antonio Jimeno et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Fluorouracil, Leucovorin, and Oxaliplatin With and Without Cetuximab in the First-Line Treatment of Metastatic Colorectal Cancer
Carsten Bokemeyer et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
A Multicenter Blinded Study to Evaluate KRAS Mutation Testing Methodologies in the Clinical Setting
Vicki Whitehall et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2009)
Application of COLD-PCR for improved detection of KRAS mutations in clinical samples
Zhuang Zuo et al.
MODERN PATHOLOGY (2009)
Implications for KRAS status and EGFR-targeted therapies in metastatic CRC
Nicola Normanno et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2009)
Genetic analysis of KRAS mutation status in metastatic colorectal cancer patients
K. Zavodna et al.
NEOPLASMA (2009)
K-rasMutations and Cetuximab in Colorectal Cancer
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
Eric Van Cutsem et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
KRAS mutation testing for predicting response to anti-EGFR therapy for colorectal carcinoma: proposal for an European quality assurance program
J. H. J. M. van Krieken et al.
VIRCHOWS ARCHIV (2009)
Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer
Rafael G. Amado et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents:: a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancer
Helena Linardou et al.
LANCET ONCOLOGY (2008)
K-ras mutations and benefit from cetuximab in advanced colorectal cancer
Christos S. Karapetis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
K-ras mutation detection in colorectal cancer using the Pyrosequencing technique
Angela Poehlmann et al.
PATHOLOGY RESEARCH AND PRACTICE (2007)
Hyperactive Ras in developmental disorders and cancer
Suzanne Schubbert et al.
NATURE REVIEWS CANCER (2007)
A multiplex PCR predictor for aCGH success of FFPE samples
EH van Beers et al.
BRITISH JOURNAL OF CANCER (2006)
Sensitive Sequencing method for KRAS mutation detection by pyrosequencing
S Ogino et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2005)
Recovering DNA and optimizing PCR conditions from microdissected formalin-fixed and paraffin-embedded materials
ZP Ren et al.
PATHOBIOLOGY (2000)
Share Paper
